Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid Arthritis.
Hawre JalalJames R O'DellS Louis BridgesStacey CofieldJeffrey R CurtisTed R MikulsLarry W MorelandKaleb D MichaudPublished in: Arthritis care & research (2016)
IT was highly cost-effective in the majority of scenarios. Although IE was more effective in 5 years, a substantial reduction in the cost of biologic agents was required in order for IE to become cost-effective in early aggressive RA under willingness-to-pay thresholds that most health care settings may find acceptable.